Surface Oncology Inc. sell tbackenh
Start price
20.09.21
/
50%
€6.37
Target price
20.09.22
€5.00
Performance (%)
-29.23%
End price
05.12.21
€4.51
Summary
This prediction ended on 05.12.21 with a price of €4.51. The prediction for Surface Oncology Inc. closed with a convincing performance of -29.23%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Surface Oncology Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to tbackenh what are the pros and cons of Surface Oncology Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Very low/no dividend yield expected
Risky balance sheet
Comments by tbackenh for this prediction
In the thread Surface Oncology Inc. diskutieren
Sell mit Kursziel 5,0